Description: Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug for the treatment of colorectal cancer; Gemcitabine Yakult, an antineoplastic antimetabolite; Zoledronic acid Yakult, a bone resorption inhibitor; and Docetaxel Yakult, a generic taxoid antineoplastic drug. In addition, the company offers cosmetics and skin care products under the Parabio, Revecy, and Revecy White brand names; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
Home Page: www.yakult.co.jp
10-30, Kaigan, 1-chome
Tokyo,
105-8660
Japan
Phone:
81 3 6625 8960
Officers
| Name | Title |
|---|---|
| Mr. Hiroshi Narita | Chairman, Pres & CEO |
| Hiroshi Wakabayashi | Exec. VP, GM of Admin. Headquarters & Director |
| Mr. Fumiyasu Ishikawa | Sr. Managing Exec. Officer, GM of R&D Division and Director |
| Mr. Masanori Ito | Managing Exec. Officer, GM of Pharmaceuticals Bus. Division & Director |
| Susumu Hirano | Sr. Managing Exec. Officer, GM of International Bus. Division & Director |
| Akifumi Doi | Sr. Managing Exec. Officer, GM of Production Headquarters & Director |
| Tetsuya Hayashida | Sr. Managing Exec. Officer, GM of Food Bus. & Cosmetics Bus. HQ and Director |
| Koichi Hirano | Managing Exec. Officer & Director |
| Masanobu Nanno | Managing Exec. Officer |
| Masao Imada | Sr. Managing Exec. Officer, GM of Management Support Division & Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 26.1097 |
|---|---|
| Trailing PE: | 30.9324 |
| Price-to-Book MRQ: | 2.74 |
| Price-to-Sales TTM: | 0.0227 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 29273 |